Steven King compensation by year
Avid Bioservices Summary Compensation Table · all 3 fiscal years held| Component | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Salary | $520,000 | $540,000 | $374,400 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $316,860 | $209,500 | $0 |
| Non-equity incentive | $362,000 | $281,941 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $51,043 | $51,365 | $310,218 |
| Total | $1,249,903 | $1,082,806 | $684,618 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avid Bioservices, Inc. DEF 14A filed August 17, 2018, accession 0001683168-18-002408, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Avid Bioservices, Inc. filed document, accession 0001683168-18-002408. Every figure is read from that document and cited to the page and table it appears in. Filed August 17, 2018.
Avid Bioservices’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Roger Lias | President and Chief Executive Officer | $704,347 |
| Steven King · this page | Former President and Chief Executive Officer | $684,618 |
| Joseph Shan | Former Vice President, Clinical & Regulatory Affairs | $601,473 |
| Paul Lytle | Chief Financial Officer | $463,125 |
| Mark Ziebell | Vice President, General Counsel and Corporate Secretary | $409,484 |
The full Avid Bioservices compensation record
free company briefThis page is one person within Avid Bioservices's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Avid Bioservices proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Avid Bioservices's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.